These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1365 related articles for article (PubMed ID: 17671115)

  • 1. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional and phenotypic characteristics of CD4+CD25highFoxp3+ Treg clones obtained from peripheral blood of patients with cancer.
    Strauss L; Bergmann C; Whiteside TL
    Int J Cancer; 2007 Dec; 121(11):2473-83. PubMed ID: 17691114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease.
    Bergmann C; Strauss L; Wang Y; Szczepanski MJ; Lang S; Johnson JT; Whiteside TL
    Clin Cancer Res; 2008 Jun; 14(12):3706-15. PubMed ID: 18559587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma.
    Bergmann C; Strauss L; Zeidler R; Lang S; Whiteside TL
    Cancer Res; 2007 Sep; 67(18):8865-73. PubMed ID: 17875728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equine CD4(+) CD25(high) T cells exhibit regulatory activity by close contact and cytokine-dependent mechanisms in vitro.
    Hamza E; Gerber V; Steinbach F; Marti E
    Immunology; 2011 Nov; 134(3):292-304. PubMed ID: 21977999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β
    Rathod SB; Tripathy AS
    Hum Immunol; 2016 Dec; 77(12):1254-1263. PubMed ID: 27720959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck.
    Strauss L; Bergmann C; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Nov; 13(21):6301-11. PubMed ID: 17975141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
    Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
    Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal interleukin-33 promotes regulatory T cell-mediated immunosuppression in head and neck squamous cell carcinoma and correlates with poor prognosis.
    Wen YH; Lin HQ; Li H; Zhao Y; Lui VWY; Chen L; Wu XM; Sun W; Wen WP
    Cancer Immunol Immunother; 2019 Feb; 68(2):221-232. PubMed ID: 30357458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression.
    Strauss L; Bergmann C; Szczepanski MJ; Lang S; Kirkwood JM; Whiteside TL
    J Immunol; 2008 Mar; 180(5):2967-80. PubMed ID: 18292519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased frequency of CD4+CD25(high)FoxP3+ regulatory T cells in patients with hepatocellular carcinoma.
    Feng X; Li B; Ye H; Long D
    Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):309-14. PubMed ID: 21633918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose splenic radiation inhibits liver tumor development of rats through functional changes in CD4+CD25+Treg cells.
    Wang B; Li B; Dai Z; Ren S; Bai M; Wang Z; Li Z; Lin S; Wang Z; Huang N; Yang P; Liu M; Min W; Ma H
    Int J Biochem Cell Biol; 2014 Oct; 55():98-108. PubMed ID: 25168696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human retinal pigment epithelium-induced CD4+CD25+ regulatory T cells suppress activation of intraocular effector T cells.
    Horie S; Sugita S; Futagami Y; Yamada Y; Mochizuki M
    Clin Immunol; 2010 Jul; 136(1):83-95. PubMed ID: 20350837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intense Foxp3+ CD25+ regulatory T-cell infiltration is associated with high-grade cutaneous squamous cell carcinoma and counterbalanced by CD8+/Foxp3+ CD25+ ratio.
    Azzimonti B; Zavattaro E; Provasi M; Vidali M; Conca A; Catalano E; Rimondini L; Colombo E; Valente G
    Br J Dermatol; 2015 Jan; 172(1):64-73. PubMed ID: 24910265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro induction of functional allergen-specific CD4+ CD25high Treg cells in horses affected with insect bite hypersensitivity.
    Hamza E; Akdis CA; Wagner B; Steinbach F; Marti E
    Clin Exp Allergy; 2013 Aug; 43(8):889-901. PubMed ID: 23889243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic immune tuning in renal cell carcinoma: favorable prognostic impact of TGF-β1 mRNA expression in peripheral blood mononuclear cells.
    Busse A; Asemissen A; Nonnenmacher A; Ochsenreither S; Fusi A; Braun F; Stather D; Schmittel A; Miller K; Thiel E; Keilholz U
    J Immunother; 2011 Jan; 34(1):113-9. PubMed ID: 21150720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased prevalence of interleukin-17-producing CD4(+) tumor infiltrating lymphocytes in human oral squamous cell carcinoma.
    Lee JJ; Chang YL; Lai WL; Ko JY; Kuo MY; Chiang CP; Azuma M; Chen CW; Chia JS
    Head Neck; 2011 Sep; 33(9):1301-8. PubMed ID: 21837700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
    Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
    Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis.
    Strauss L; Bergmann C; Whiteside TL
    J Immunol; 2009 Feb; 182(3):1469-80. PubMed ID: 19155494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.